Back to search

France· FR:60468092

NOVOPULMON NOVOLIZER 200 microgrammes/dose, poudre pour inhalation

A medicinal product containing budésonide, registered in France by VIATRIS MEDICAL, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNOVOPULMON NOVOLIZER 200 microgrammes…ATC—REGISTER NO.FR:60468092PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
BUDÉSONIDE
Manufacturer
VIATRIS MEDICAL
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400936293885
    1 cartouche(s) acrylonitrile butadiène styrène polypropylène de 200 dose(s) avec inhalateur(s)
    EUR 20.42
  • cip13
    3400936294028
    1 cartouche(s) acrylonitrile butadiène styrène polypropylène de 200 dose(s)
    EUR 15.76

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Budésonide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All budésonide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Budenofalk, Budo-San
  • Belgium · Budenofalk, Budesonid Sandoz
  • Bulgaria · Airbudenid, Буденофалк
  • Cyprus · Axelovert, Biosonide
  • Czechia · Budenofalk, Budenofalk Uno
  • Germany · Aquacort, Budapp Nasal
  • Denmark · Benarhin, Budenofalk
  • Estonia · Budesonid Sandoz, Budesonide
  • Spain · Budena, Budesonida
  • Finland · Budenofalk, Budesonid Easyhaler Orion
  • United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
  • Greece · Aurid, Axelovert
  • Croatia · Budelin Novolizer, Budosan
  • Hungary · Budenofalk, Budesonid Easyhaler
  • Ireland · Budenofalk, Budesonide Azure
  • Iceland · Budesonide Stada, Cortiment
  • Italy · Aircort, Bidien
  • Liechtenstein · Jorveza, Kinpeygo
  • Lithuania · Budenofalk, Budesonide Ferring
  • Luxembourg · Budenofalk, Budesonide Eg
  • Latvia · Budenofalk, Budesonid Sandoz
  • Malta · Budesonida Aldo-Unión, Budesonide Azure
  • Netherlands · Budenofalk, Budenofalk Schuim
  • Norway · Budenofalk, Budesonid Medical Valley
  • Poland · Bds N, Benodil
  • Portugal · Aeromax, Budenofalk
  • Romania · Budenofalk, Budenofalk Uno
  • Sweden · Budaxiro, Budenofalk
  • Slovenia · Budenofalk, Budesonid Easyhaler Orion
  • Slovakia · Budelin Novolizer, Budenofalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3083a05-2a68-4bfd-8b45-d6ad34225b49
GET /v1/drugs/b3083a05-2a68-4bfd-8b45-d6ad34225b49?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60468092",
  "date_amm": "2003-10-29",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "BUDÉSONIDE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour inhalation",
  "voies_administration": "inhalée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about budésonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.